2.5250
+0.0800
+(3.27%)
As of 2:05:08 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-22,974.2340
-39,967.3040
-17,312.9340
-9,132.1590
-3,970.8230
Financing Cash Flow
29,255.9220
17,344.3310
4.6130
46,743.5150
12,043.6230
End Cash Position
12,636.6300
5,754.7200
28,377.6930
45,686.0140
8,074.6580
Issuance of Capital Stock
20,780.9200
16,885.9460
--
46,648.4130
12,034.4060
Free Cash Flow
-22,974.2340
-39,967.3040
-17,312.9340
-9,132.1590
-3,970.8230
12/31/2020 - 7/9/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AAVXF ABIVAX Société Anonyme
5.89
0.00%
DBV.PA DBV Technologies S.A.
0.8450
+4.19%
TECX Tectonic Therapeutic, Inc.
31.60
-0.85%
DYN Dyne Therapeutics, Inc.
13.92
+2.96%
BCTX BriaCell Therapeutics Corp.
3.7800
+10.20%
VLA.PA Valneva SE
3.7000
-4.59%
AVXL Anavex Life Sciences Corp.
8.70
+4.95%
RNAZ TransCode Therapeutics, Inc.
10.78
-0.46%
OCEA Ocean Biomedical, Inc.
0.1738
-13.10%